Piper Sandler analyst David Amsellem downgraded Xeris Biopharma (XERS) to Neutral from Overweight with an unchanged price target of $3, post ...

Piper Sandler analyst David Amsellem downgraded the rating on Xeris Pharmaceuticals (XERS – Research Report) to a Hold yesterday, setting ...

Q3 2024 Earnings Call Transcript November 6, 2024Amphastar Pharmaceuticals, Inc. misses on earnings expectations.

Operator: Good day, and welcome to the Third Quarter 2024 Pacira Biosciences Inc. Earnings Conference Call. At this time, all ...

The stock of Ironwood Pharmaceuticals Inc (IRWD) has seen a 5.46% increase in the past week, with a -1.77% drop in the past month, and a -33.93% decrease in the past quarter. The volatility ratio for ...

Thanks for the question. Operator: Our next question comes from the line of David Amsellem with Piper Sandler. Please go ahead. David Amsellem: Thanks. So just a couple for me. So now that you have ...

NEW YORK, Oct. 31, 2024 /PRNewswire/ -- Piper Sandler Companies (NYSE: PIPR), a leading investment bank, and BC Partners Credit, the $8 billion credit arm of international investment firm BC ...

NEW YORK - Piper Sandler Companies (NYSE: PIPR), a prominent investment bank, and BC Partners Credit have announced a strategic alliance aimed at enhancing debt capital market access for financial ...

On Monday, Piper Sandler maintained an Overweight rating on shares of Yeti Holdings Inc. (NYSE:NYSE:YETI), with a steady price target of $55.00. The firm expressed confidence in the company's ...

Fastly (NYSE:FSLY) shares slipped fractionally in premarket trading on Thursday, even as investment firm Piper Sandler upped its price target on the content delivery company after it reported ...

Piper Sandler raised the firm’s price target on Mondelez (MDLZ) to $84 from $74 and keeps an Overweight rating on the shares. The firm notes Mondelez reported better than expected Q3 EPS and ...